Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Mortality 69% Improvement Relative Risk Vitamin D  Gholamalizadeh et al.  ICU PATIENTS Is very late treatment with vitamin D beneficial for COVID-19? Retrospective 200 patients in Iran Lower mortality with vitamin D (p=0.04) Survival bias may be significant c19early.org Gholamalizadeh et al., Immunity, Infla.., Apr 2023 Favors vitamin D Favors control

The association between vitamin D intake with inflammatory and biochemical indices and mortality in critically ill patients with COVID‐19: A case‐control study

Gholamalizadeh et al., Immunity, Inflammation and Disease, doi:10.1002/iid3.844
Apr 2023  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 120 studies, recognized in 8 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
Case control study with 200 critical COVID-19 patients in Iran, showing lower mortality with higher vitamin D supplement intake. Authors do not provide enough information to assess confounding. Authors indicate that treatment was based on the opinion of the treating physician, and include only patients with at least one week in the ICU, however patients that die may have lower vitamin D supplement duration because they are no longer alive.
Cholecalciferol was used in this study. Meta analysis shows that late stage treatment with calcitriol / calcifediol (or paricalcitol, alfacalcidol, etc.) is more effective than cholecalciferol: 65% [41‑79%] lower risk vs. 39% [26‑49%] lower risk. Cholecalciferol requires two hydroxylation steps to become activated - first in the liver to calcifediol, then in the kidney to calcitriol. Calcitriol, paricalcitol, and alfacalcidol are active vitamin D analogs that do not require conversion. This allows them to have more rapid onset of action compared to cholecalciferol. The time delay for cholecalciferol to increase serum calcifediol levels can be 2-3 days, and the delay for converting calcifediol to active calcitriol can be up to 7 days.
This study is excluded in meta analysis: survival bias may significantly affect results.
risk of death, 68.8% lower, OR 0.31, p = 0.04, inverted to make OR<1 favor treatment, model 3, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Gholamalizadeh et al., 26 Apr 2023, Iran, peer-reviewed, 13 authors. Contact: doaei@gums.ac.ir, profmeakbari@gmail.com.
This PaperVitamin DAll
The association between vitamin D intake with inflammatory and biochemical indices and mortality in critically ill patients with COVID‐19: A case‐control study
Maryam Gholamalizadeh, Faezeh Rabbani, Mina Ahmadzadeh, Azadeh Hajipour, Hayehe Musavi, Khadijeh Abbasi Mobarakeh, Zahra Salimi, Bojlul Bahar, Zahra Mahmoodi, Somayeh Gholami, Samaneh Mirzaei Dahka, Saeid Doaei, Mokammad Esmail Akbari
Immunity, Inflammation and Disease, doi:10.1002/iid3.844
Background: The coronavirus disease-2019 (COVID-19) has become a worldwide health issue with widespread hospitalization and dependence on the intensive care unit (ICU). Vitamin D has a key role in modulating immune cells and modulating the inflammatory responses. This study aimed to investigate the association of vitamin D supplementation with inflammatory, biochemical, and mortality indices in critically ill patients with COVID-19. Methods: This case-control study was conducted on critically ill COVID-19 patients hospitalized in the ICU including the survived >30 day patients as the case group and dead patients as the control group. The status of vitamin D
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest. ETHICS STATEMENT This study was approved by the Institutional Review Board at Shahid-Beheshti University of Medical Sciences (code: IR.SBMU.CRC.REC.1399.031). All patients signed an informed consent form at baseline. Institutional consent forms were used in this study.
References
Abdollahi, Sarvestani, Rafat, The association between the level of serum 25(OH) vitamin D, obesity, and underlying diseases with the risk of developing COVID-19 infection: a case-control study of hospitalized patients in Tehran, Iran, J Med Virol
Amrein, Hoffmann, Lobmeyr, Martucci, Vitamin D in critical care: where are we now and what is next?, Curr Opin Crit Care
Amrein, Scherkl, Hoffmann, Vitamin D deficiency 2.0: an update on the current status worldwide, Eur J Clin Nutr
Arboleda, Urcuqui-Inchima, Vitamin D supplementation: a potential approach for coronavirus/covid-19 therapeutics?, Front Immunol
Ashraf, Abokor, Edwards, SARS-CoV-2, ACE2 expression, and systemic organ invasion, Physiol Genomics
Bania, Pitsikakis, Mavrovounis, Therapeutic vitamin D supplementation following COVID-19 diagnosis: where do we stand?-a systematic review, J Pers Med
Barek, Aziz, Islam, Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: a meta-analysis with 55 studies and 10014 cases, Heliyon
Beyerstedt, Casaro, Rangel, COVID-19: angiotensinconverting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection, Eur J Clin Microbiol Infect Dis
Bignardi, Castello, Aquino, Association between vitamin D and COVID-19: a systematic review and meta-analysis
Bilezikian, Bikle, Hewison, Mechanisms in endocrinology: vitamin D and COVID-19, Eur J Endocrinol
Brice, Diamond, Antiviral activities of human host defense peptides, Curr Med Chem
Brito, Ribeiro, Daltro, Silva, The possible benefits of vitamin D in COVID-19, Nutrition
Caballero-García, Pérez-Valdecantos, Guallar, Effect of vitamin D supplementation on muscle status in old patients recovering from COVID-19 infection, Medicina
Castillo, Costa, Barrios, Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study, J Steroid Biochem Mol Biol
Cattermole, Graham, Rainer, Mid-arm circumference can be used to estimate weight of adult and adolescent patients, Emerg Med J
Corrao, Bocchio, Monaco, Does evidence exist to blunt inflammatory response by nutraceutical supplementation during covid-19 pandemic? An overview of systematic reviews of vitamin d, vitamin c, melatonin, and zinc, Nutrients
D'ecclesiis, Gavioli, Martinoli, Vitamin D and SARS-CoV2 infection, severity and mortality: a systematic review and meta-analysis, PLoS One
Elamir, Amir, Lim, A randomized pilot study using calcitriol in hospitalized COVID-19 patients, Bone
Farhud, Mehrabi, Sarafnejad, A epidemiological and ecological descriptive study on vitamin D status in Iran (308005 people, from 2009-2018), Iran J Public Health
Farid, Rola, Koch, Nakhoul, Active vitamin D supplementation and COVID-19 infections: review, Irish J Med Sci
Filho, De Andrade, Ribeiro, Alves, Simonini, Impact of vitamin D deficiency on increased blood eosinophil counts, Hematol/Oncol Stem Cell Therapy
Fiore, Vito, Bagella, Effectiveness of vitamin D supplements among patients hospitalized for COVID-19: results from a monocentric matched-cohort study, Healthcare
Frater, Zini, Onofrio, Rogers, COVID-19 and the clinical hematology laboratory, Int J Lab Hematol
Gasmi, Tippairote, Mujawdiya, Micronutrients as immunomodulatory tools for COVID-19 management, Clin Immunol
Getachew, Tizabi, Vitamin D and COVID-19: role of ACE2, age, gender, and ethnicity, J Med Virol
Ghazanfari, Salehi, Namaki, Interpretation of hematological, biochemical, and immunological findings of COVID-19 disease: biomarkers associated with severity and mortality, Iran J Allergy Asthma Immunol
Giammaria, Pajewski, Can early treatment of patients with risk factors contribute to managing the COVID-19 pandemic?, J Glob Health
Gibbons, Norton, Mccullough, Association between vitamin D supplementation and COVID-19 infection and mortality, Sci Rep
Gilani, Bin-Jumah, Nadeem, Kazmi, Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy, Expert Rev Anti Infect Ther
Grant, Lahore, Mcdonnell, Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths, Nutrients
Grant, Lahore, Rockwell, The benefits of vitamin D supplementation for athletes: better performance and reduced risk of COVID-19, Nutrients
Hahn, Cook, Alexander, Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial, BMJ
Hariyanto, Intan, Hananto, Harapan, Kurniawan, Vitamin D supplementation and Covid-19 outcomes: a systematic review, meta-analysis and meta-regression, Rev Med Virol
Henry, De Oliveira, Benoit, Plebani, Lippi, Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis, Clin Chem Lab Med (CCLM)
Henry, Lippi, Plebani, Laboratory abnormalities in children with novel coronavirus disease 2019, Clinical Chem Lab Med (CCLM)
Hill, Starchl, Dresen, Stoppe, Amrein, Vitamin C and D supplementation in critically ill patients, Med Klin Intensivmed Notfmed
Hosseini, El Abd, Ducharme, Effects of vitamin D supplementation on COVID-19 related outcomes: a systematic review and meta-analysis, Nutrients
Jakovac, COVID-19 and vitamin D-is there a link and an opportunity for intervention?, Am J Physiol-Endocrinol Metab
Jayawardena, Jeyakumar, Francis, Misra, Impact of the vitamin D deficiency on COVID-19 infection and mortality in Asian countries, Diabetes Metabolic Syndrome
Khan, Nasir, Nasir, Maha, Rehman, Vitamin D and COVID-19: is there a role?, J Diabetes Metab Disord
Khorasanchi, Esfehani, Sharifan, The effects of high dose vitamin D supplementation as a nutritional intervention strategy on biochemical and inflammatory factors in adults with COVID-19: study protocol for a randomized controlled trial, Nutr Health
Mahdavi, Rabbani, Ahmadzadeh, The association between vitamin D intake with inflammatory and biochemical indices and mortality in critically ill patients with COVID-19: a case-control study, Immun Inflamm Dis
Mansur, Tajer, Mariani, Inserra, Ferder et al., Vitamin D high doses supplementation could represent promising alternative to prevent or treat COVID-19 infection, Clínica e Investigación en Arteriosclerosis (English Edition)
Mercola, Grant, Wagner, Evidence regarding vitamin D and risk of COVID-19 and its severity, Nutrients
Mirmiran, Hosseini Esfahani, Mehrabi, Hedayati, Azizi, Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study, Public Health Nutr
Muñoz, Grant, Vitamin D and cancer: an historical overview of the epidemiology and mechanisms, Nutrients
Nasiri, Khodadadi, Molaei, Does vitamin D serum level affect prognosis of COVID-19 patients?, Int J Infect Dis
Nielsen, Junker, Boelt, Vitamin D status and severity of COVID-19, Sci Rep
Niet, Trémège, Coffiner, Positive effects of vitamin D supplementation in patients hospitalized for COVID-19: a randomized, double-blind, placebo-controlled trial, Nutrients
Nikniaz, Akbarzadeh, Hosseinifard, Hosseini, The impact of vitamin D supplementation on mortality rate and clinical outcomes of COVID-19 patients: a systematic review and meta-analysis, MedRxiv
Nimavat, Singh, Singh, Singh, Sinha, Vitamin D deficiency and COVID-19: a case-control study at a tertiary care hospital in India, Ann Med Surg
Oristrell, Oliva, Casado, Vitamin D supplementation and COVID-19 risk: a population-based, cohort study, J Endocrinol Invest
Pacha, Sallman, Evans, COVID-19: a case for inhibiting IL-17?, Nat Rev Immunol
Pal, Banerjee, Bhadada, Shetty, Singh et al., Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis, J Endocrinol Invest
Pal, Bhansali, COVID-19, diabetes mellitus and ACE2: the conundrum, Diabetes Res Clin Pract
Pimentel, Vega, Pichard, Low vitamin D levels and increased neutrophil in patients admitted at ICU with COVID-19, Clinical Nutrition ESPEN
Pourbagheri-Sigaroodi, Bashash, Fateh, Abolghasemi, Laboratory findings in COVID-19 diagnosis and prognosis, Clin Chim Acta
Qayyum, Mohammad, Slominski, Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes, Am J Physiol-Endocrinol Metab
Rastogi, Bhansali, Khare, Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study), Postgrad Med J
Raucci, Mansour, Casillo, Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms, Autoimmun Rev
Rawat, Roy, Maitra, Shankar, Khanna et al., Vitamin D supplementation and COVID-19 treatment: a systematic review and meta-analysis, Diabetes Metabolic Syndrome
Sabico, Enani, Sheshah, Effects of a 2-week 5000 IU versus 1000 IU vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate Covid-19: a randomized clinical trial, Nutrients
Shah, Saxena, Mavalankar, Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis, QJM: Monthly J Assoc Phy
Simko, Hrenak, Adamcova, Paulis, Reninangiotensin-aldosterone system: friend or foe-the matter of balance. Insight on history, therapeutic implications and COVID-19 interactions, Int J Mol Sci
Slominski, Chaiprasongsuk, Janjetovic, Photoprotective properties of vitamin D and lumisterol hydroxyderivatives, Cell Biochem Biophys
Slominski, Stefan, Athar, COVID-19 and vitamin D: a lesson from the skin, Exp Dermatol
Szarpak, Filipiak, Gasecka, Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis, Cardiol J
Tabrizi, Moosazadeh, Akbari, High prevalence of vitamin D deficiency among Iranian population: a systematic review and meta-analysis, Iran J Med Sci
Tarnowski, Rabito, Fernandes, Height prediction from ulna length of critically ill patients, Nutr Clin Pract
Tentolouris, Samakidou, Eleftheriadou, Tentolouris, Jude, The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and metaregression, Diabetes Metab Res Rev
Tjendra, Mana, Espejo, Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers, Arch Pathol Lab Med
Turrubiates-Hernández, Sánchez-Zuno, González-Estevez, Hernández-Bello, Macedo-Ojeda et al., Potential immunomodulatory effects of vitamin D in the prevention of severe coronavirus disease 2019: an ally for Latin America, Int J Mol Med
Varikasuvu, Thangappazham, Vykunta, COVID-19 and vitamin D (Co-VIVID study): a systematic review and metaanalysis of randomized controlled trials, Expert Rev Anti Infect Ther
Vasheghani, Jannati, Baghaei, Rezaei, Aliyari et al., The relationship between serum 25-hydroxyvitamin D levels and the severity of COVID-19 disease and its mortality, Sci Rep
Vassiliou, Jahaj, Orfanos, Dimopoulou, Kotanidou, Vitamin D in infectious complications in critically ill patients with or without COVID-19, Metabolism Open
Vatandost, Jahani, Afshari, Amiri, Heidarimoghadam et al., Prevalence of vitamin D deficiency in Iran: a systematic review and meta-analysis, Nutr Health
Xue, Gan, Wu, Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19, Int Immunopharmacol
Yang, Yu, Xu, Clinical course outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respiratory Med
Yaqinuddin, Ambia, Alaujan, Immunomodulatory effects of vitamin D and vitamin C to improve immunity in COVID-19 patients, J Health Allied Sci NU
Zou, Yan, Shu, Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections, Nat Commun
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit